# Isolation, Characterization and Biological Evaluation of Collagen from Rhizostoma pulmo Jellyfish from the Sea of Azov for Biomedical Applications

**Authors:** Oleg Kit, Sergey Golovin, Evgeniya Kirichenko, Alina Sereda, Yulia Gordeeva, Evgeniy Sadyrin, Andrey Nikolaev, Pavel Antipov, Aleksandr Logvinov, Maria Kaplya, Magomed Abdulkadyrov, Stanislav Rodkin

PMC · DOI: 10.3390/md24030109 · 2026-03-13

## TL;DR

This paper explores collagen from Azov Sea jellyfish as a safe and sustainable material for biomedical uses like tissue engineering and wound healing.

## Contribution

The study introduces Rhizostoma pulmo jellyfish collagen as a novel marine source with potential for biomedical applications.

## Key findings

- Extracted collagen showed high yield (~26.2%) and a type I-like profile with α-, β-, and γ-components.
- Collagen sponges supported 3D cell growth and tumor-cell dissemination in an in vitro breast carcinoma model.
- Low endotoxin levels (0.461 EU/µL) and no cytotoxicity were observed in tested conditions.

## Abstract

Collagen is a major extracellular-matrix protein widely used in regenerative medicine, yet conventional terrestrial sources raise biosafety and acceptability concerns, motivating the search for marine alternatives. This study evaluates the jellyfish Rhizostoma pulmo (R. pulmo) from the Azov Sea as a sustainable collagen source and assesses its suitability for biomedical materials. Acid-soluble collagen was extracted using 0.5 M acetic acid and purified by salt precipitation and dialysis, followed by physicochemical/structural characterization (sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE), Limulus amebocyte lysate (LAL) endotoxin testing, transmission electron microscopy (TEM), and immunofluorescence with type I collagen antibodies) and biological evaluation in vitro (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity on MRC5 fibroblasts; adhesion and proliferation assays on HeLa cells). The extracted collagen showed a high yield (~26.2%), a type I-like electrophoretic profile with α-, β-, and γ-components, fibrillar ultrastructure by TEM, and positive type I collagen immunoreactivity; endotoxin levels were low (0.461 EU/µL), and no cytotoxicity was detected under the tested conditions. Porous collagen sponges/scaffolds were fabricated by lyophilization, displaying interconnected pores with an average size of ~80 µm and pH-dependent swelling, and they supported 3D cell growth and tumor-cell dissemination in an in vitro breast carcinoma scaffold model. Overall, Azov Sea R. pulmo collagen demonstrates promising structural quality, low endotoxin burden, and cytocompatibility, supporting its potential as a marine biomaterial for sponge/scaffold-based tissue engineering and wound-related applications.

## Linked entities

- **Proteins:** COL3A1 (collagen type III alpha 1 chain)
- **Chemicals:** acetic acid (PubChem CID 176), sodium dodecyl sulfate (PubChem CID 3423265), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (PubChem CID 64965), endotoxin (PubChem CID 53481793)
- **Diseases:** breast carcinoma (MONDO:0004989)
- **Species:** Rhizostoma pulmo (taxon 269554)

## Full-text entities

- **Genes:** COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688] {aka AGM10, OF, PU.1, SFPI1, SPI-1, SPI-A}, GPHA2 (glycoprotein hormone subunit alpha 2) [NCBI Gene 170589] {aka A2, GPA2, ZSIG51}, LIPA (lipase A, lysosomal acid type) [NCBI Gene 3988] {aka CESD, LAL}, Vim (vimentin) [NCBI Gene 22352], ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, BCL2A1 (BCL2 related protein A1) [NCBI Gene 597] {aka ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1}
- **Diseases:** tumor (MESH:D009369), weight loss (MESH:D015431), Breast Carcinoma (MESH:D001943), Swelling (MESH:D004487), mycoplasma (MESH:D009175), inflammation (MESH:D007249), eye dryness (MESH:D014987), injury to (MESH:D014947), hemorrhage (MESH:D006470), Cytotoxicity (MESH:D064420), corneal damage (MESH:D065306)
- **Chemicals:** 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), formalin (MESH:D005557), magnesium (MESH:D008274), potassium iodide (MESH:D011193), tiletamine hydrochloride (MESH:D013992), paraffin (MESH:D010232), xylazine (MESH:D014991), epoxy resin (MESH:D004853), phosphomolybdic acid (MESH:C003125), povidone-iodine (MESH:D011206), phosphate (MESH:D010710), oil (MESH:D009821), glycosaminoglycans (MESH:D006025), H2O2 (MESH:D006861), H&amp;E (MESH:D006371), dimethyl sulfoxide (MESH:D004121), Sytox Green (MESH:C402795), PBS (MESH:D007854), amino acid (MESH:D000596), picric acid (MESH:C005858), glutaraldehyde (MESH:D005976), Coomassie blue (MESH:C048139), HCl (MESH:D006851), lipopolysaccharides (MESH:D008070), hematoxylin (MESH:D006416), propylene oxide (MESH:C009068), CO2 (MESH:D002245), DPBS (MESH:C012939), Polyacrylamide (MESH:C016679), MTT (MESH:C070243), isopropanol (MESH:D019840), trypan blue (MESH:D014343), water (MESH:D014867), NaCl (MESH:D012965), aniline blue (MESH:C017006), calcium (MESH:D002118), telazol (MESH:C006131), Iodine (MESH:D007455), heparan sulfate (MESH:D006497), -diaminobenzidine tetrachloride (-), Epon-812 (MESH:C004875), carbon (MESH:D002244), oxygen (MESH:D010100), Triton X-100 (MESH:D017830), ethanol (MESH:D000431), L-glutamine (MESH:D005973), SDS (MESH:D012967), formazan (MESH:D005562), bromophenol blue (MESH:D001978), eosin (MESH:D004801), alcohols (MESH:D000438), chitosan (MESH:D048271), paraformaldehyde (MESH:C003043), heparin (MESH:D006493), CS (MESH:D002586), zolazepam hydrochloride (MESH:D015041), acetic acid (MESH:D019342), glycerol (MESH:D005990), EDTA (MESH:D004492), uranyl acetate (MESH:C005460)
- **Species:** prion (species) [taxon 36469], Rattus norvegicus (brown rat, species) [taxon 10116], Rhizostoma pulmo (species) [taxon 269554], Bacillus sp. SA (species) [taxon 1168094], Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rhopilema esculentum (species) [taxon 499914]
- **Cell lines:** BT20 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0178), MRC-5 — Homo sapiens (Human), Finite cell line (CVCL_0440), BT29 — Homo sapiens (Human), Amyotrophic lateral sclerosis 1, Induced pluripotent stem cell (CVCL_8999), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027746/full.md

---
Source: https://tomesphere.com/paper/PMC13027746